|
Volumn 30, Issue 6, 2010, Pages 827-828
|
Treatment of relapsing polychondritis in the era of biological agents
|
Author keywords
Biologic agents; Relapsing polychondritis; Rituximab
|
Indexed keywords
AZATHIOPRINE;
C REACTIVE PROTEIN;
CORTICOSTEROID;
CYCLOSPORIN A;
INFLIXIMAB;
METHOTREXATE;
RITUXIMAB;
ADULT;
ANGIOCARDIOGRAPHY;
AORTA DISEASE;
AORTA VALVE STENOSIS;
AORTIC VALVE REPAIR;
ARTICLE;
CASE REPORT;
CLINICAL FEATURE;
DRUG DOSE INCREASE;
DRUG EFFICACY;
DYSPNEA;
EAR MALFORMATION;
HUMAN;
MALE;
NOSE MALFORMATION;
PERCEPTION DEAFNESS;
PRIORITY JOURNAL;
RELAPSING POLYCHONDRITIS;
SINUSITIS;
THORAX PAIN;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
AORTIC VALVE;
AORTIC VALVE INSUFFICIENCY;
AZATHIOPRINE;
C-REACTIVE PROTEIN;
CARDIAC SURGICAL PROCEDURES;
COLLAGEN;
HEARING LOSS, SENSORINEURAL;
HUMANS;
IMMUNITY, CELLULAR;
IMMUNOSUPPRESSIVE AGENTS;
LYMPHOCYTE ACTIVATION;
MALE;
MIDDLE AGED;
POLYCHONDRITIS, RELAPSING;
TREATMENT OUTCOME;
|
EID: 77951023169
PISSN: 01728172
EISSN: None
Source Type: Journal
DOI: 10.1007/s00296-009-1308-6 Document Type: Article |
Times cited : (20)
|
References (9)
|